Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict

Takeda confirmed it would appeal the outcome, stating that the case “lacks merit”.

Latest news

UK government bolsters antiviral supply for hantavirus

The UK has received a supply of favipiravir from the Japanese government to aid Hantavirus preparedness.

QIAGEN and NVIDIA partner on AI drug discovery

The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.

Clinical Trials Day 2026: ‘Research Rising’ theme reflected in Q1 study growth

As China continues to inch ahead of competition in terms of trial initiations, immunology and metabolic disease trials attract sponsor eyes.

SERB signs agreement to acquire Idefirix rights for $133.6m

Hansa will receive €110m upfront and a further €5m once the European Medicines Agency accepts Idefirix’s full approval filing.

Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates

Parabilis is set to receive $125m, including a $50m upfront payment and a $75m investment, subject to agreed conditions.